A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 6, 2011, Pages 572-577

  Fischer, Craig P ^a   Wood, Christopher G ^b   Shen, Jessica ^c   Batiller, Jonathan ^c   Hart, James C ^c   Patel, Bababhai ^c   Albala, David M ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c ETHICON INC   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

aprotinin; fibrin sealant; hemostasis

Indexed keywords

APROTININ; FIBRIN GLUE; HEMOSTATIC AGENT; TRANEXAMIC ACID;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROPERITONEAL SURGERY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; APROTININ; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; RETROPERITONEAL SPACE; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053197227     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611404212     Document Type: Article

References (27)

1. Albala DM. Fibrin sealants in clinical practice. Cardiovasc Surg. 2003 ; 11 (suppl 1). 5-11 (Pubitemid 36876112)
2. Schwartz M, Madariaga J, Hirose R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004 ; 139 (11). 1148-1154 (Pubitemid 39463445)
3. Vaiman M, Sarfaty S, Shlamkovich N, Segal S, Eviatar E. Fibrin sealant: alternative to nasal packing in endonasal operations. A prospective randomized study. Isr Med Assoc J. 2005 ; 7 (9). 571-574 (Pubitemid 41309224)
4. Frilling A, Stavrou GA, Mischinger HJ, et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg. 2005 ; 390 (2). 114-120 (Pubitemid 40487434)
5. Schenk WG,, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg. 2003 ; 237 (6). 871-876 (Pubitemid 38174523)
6. Kassam A, Horowitz M, Carrau R, et al. Use of Tisseel fibrin sealant in neurosurgical procedures: incidence of cerebrospinal fluid leaks and cost-benefit analysis in a retrospective study. Neurosurgery. 2003 ; 52 (5). 1102-1105 (Pubitemid 36512974)
7. Foster JA, Holck DE, Perry JD, et al. Fibrin sealant for Müller muscle-conjunctiva resection ptosis repair. Ophthal Plast Reconstr Surg. 2006 ; 22 (3). 184-187 (Pubitemid 44510151)
8. Shah HN, Hegde S, Shah JN, Mohile PD, Yuvaraja TB, Bansal MB. A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in tubeless percutaneous nephrolithotomy. J Urol. 2006 ; 176 (6 pt 1). 2488-2492
9. Oliver DW, Hamilton SA, Figle AA, Wood SH, Lamberty BG. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast Reconstr Surg. 2001 ; 108 (7). 2101-2105 (Pubitemid 34000861)
10. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007 ; 297 (5). 471-479
11. Nur I, Bar L, Meidler R, Gorman A. Plasminogen free fibrin sealant. Poster presented at the 2006 Annual Meeting of the Society For Biomaterials, April 26-29 ; 2006 Pittsburgh, Pennsylvania ; 2006..
12. Chapman WC, Clavien PA, Fung J, Khanna A, Bonham A. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg. 2000 ; 135 (10). 1200-1204
13. Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res. 2003 ; 35 (5). 439-444 (Pubitemid 37034395)
14. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med. 1990 ; 9 (12). 1447-1454
15. Koopman PAR. Confidence intervals for the ratio of two binomial proportions. Biometrics. 1984 ; 40 (26). 513-517 (Pubitemid 16273082)
16. Aprotinin injection (marketed as Trasylol) [FDA alert]. Rockville, MD: Food and Drug Administration ; 2006 :
17. Levy JH. Efficacy and safety of aprotinin in cardiac surgery. Orthopedics. 2004 ; 27 (6 suppl). s659 - s662
18. Scheule AM, Beierlein W, Lorenz H, Ziemer G. Repeated anaphylactic reactions to aprotinin in fibrin sealant. Gastrointest Endosc. 1998 ; 48 (1). 83-85 (Pubitemid 28337438)
19. Oswald AM, Joly LM, Gury C, Disdet M, Leduc V, Kanny G. Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology. 2003 ; 99 (3). 762-763 (Pubitemid 37052003)
20. Cox S, Cole M, Mankarious S, Tawil N. Effect of tranexamic acid incorporated in fibrin sealant clots on the cell behavior of neuronal and nonneuronal cells. J Neurosci Res. 2003 ; 72 (6). 734-746 (Pubitemid 36666267)
21. Somerville, NJ: Johnson & Johnson Wound Management, a division of Ethicon, Inc ; 2008:
22. Burnouf T, Radosevich M. Nanofiltration of plasma-derived biopharmaceutical products. Haemophilia. 2003 ; 9 (1). 24-37 (Pubitemid 36511630)
23. Horowitz B, Ben-Hur E. Efforts in minimizing risk of viral transmission through viral inactivation. Ann Med. 2000 ; 32 (7). 475-484
24. Weimer T, Streichert S, Watson C, Groner A. High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion. 2001 ; 41 (12). 1500-1504 (Pubitemid 34072673)
25. Greenhalgh DG, Gamelli RL, Lee M, et al. Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn wounds. J Trauma. 1999 ; 46 (3). 433-440 (Pubitemid 29144339)
26. Rousou J, Gonzalez-Lavin L, Cosgrove D, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg. 1989 ; 97 (2). 194-203 (Pubitemid 19061421)
27. Wang GJ, Hungerford DS, Savory CG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001 ; 83-A (10). 1503-1505 (Pubitemid 32953347)